Compile Data Set for Download or QSAR
Report error Found 45 Enz. Inhib. hit(s) with all data for entry = 50000007
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239122(CHEMBL4094771)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239123(CHEMBL4078233)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239120(CHEMBL4101005)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239126(CHEMBL4067312)
Affinity DataIC50: 2nMAssay Description:Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239121(CHEMBL4082650)
Affinity DataIC50: 2.30nMAssay Description:Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239118(CHEMBL4090811)
Affinity DataIC50: 2.80nMAssay Description:Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239125(CHEMBL4083021)
Affinity DataIC50: 3nMAssay Description:Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239127(CHEMBL4086125)
Affinity DataIC50: 3.20nMAssay Description:Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239124(CHEMBL4102511)
Affinity DataIC50: 3.40nMAssay Description:Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239119(CHEMBL4062879)
Affinity DataIC50: 4.5nMAssay Description:Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239118(CHEMBL4090811)
Affinity DataIC50: 5.10nMAssay Description:Inhibition of recombinant human PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239118(CHEMBL4090811)
Affinity DataIC50: 6.10nMAssay Description:Inhibition of recombinant human PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239124(CHEMBL4102511)
Affinity DataIC50: 6.70nMAssay Description:Inhibition of recombinant human PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 7.10nMAssay Description:Inhibition of recombinant human PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239124(CHEMBL4102511)
Affinity DataIC50: 8.20nMAssay Description:Inhibition of recombinant human PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 8.60nMAssay Description:Inhibition of recombinant human PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 13nMAssay Description:Inhibition of recombinant human PI3Kalpha using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 14nMAssay Description:Inhibition of PI3Kdelta in human JeKo1 B cells assessed as decrease in AKT phosphorylation at Ser473 measured after 1 hrMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239118(CHEMBL4090811)
Affinity DataIC50: 19nMAssay Description:Inhibition of recombinant human PI3Kalpha using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239124(CHEMBL4102511)
Affinity DataIC50: 24nMAssay Description:Inhibition of recombinant human PI3Kalpha using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 190nMAssay Description:Inhibition of recombinant human PI3Kgamma using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239124(CHEMBL4102511)
Affinity DataIC50: 330nMAssay Description:Inhibition of recombinant human PI3Kgamma using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239118(CHEMBL4090811)
Affinity DataIC50: 340nMAssay Description:Inhibition of recombinant human PI3Kgamma using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of PI3Kgamma in mouse RAW264 cells assessed as decrease in AKT phosphorylation at Ser473More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetSphingosine kinase 1(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 2.90E+4nMAssay Description:Inhibition of human SphK1 (1 to 384 residues) by ATP-Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase mTOR(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 4.20E+4nMAssay Description:Inhibition of mTOR (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 4.50E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetCholine kinase alpha(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human CHKalpha (1 to 457 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetDiacylglycerol kinase beta(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human DGKbeta (1 to 804 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetDiacylglycerol kinase gamma(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human DGKgamma (1 to 752 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetCholine/ethanolamine kinase(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human CHKbeta (1 to 395 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human PI4K2alpha (1 to 479 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetPhosphatidylinositol 4-kinase beta(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human PIK4Cbeta (1 to 801 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetDiacylglycerol kinase zeta(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human DGKzeta (1 to 929 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human PI3K p85alpha (1 to 724 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human PI3K p85beta (1 to 724 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human PI3Kgamma (2 to 1102 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
TargetSphingosine kinase 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human SPHK 2 (1 to 654 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed
LigandPNGBDBM50239117(CHEMBL4060768)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human PIP5K2alpha (1 to 406 residues) by ADP Glo HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2019
Entry Details Article
PubMed